Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Biochemical Markers of ASA Chemopreventive Effect
NCT02060396Phase 1Completed
- Sponsor
- Instituto Aragonés de Ciencias de la Salud
- Start
- Apr 2013
- Primary completion
- Jun 2013
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of aspirin in colorectal cancer (CRC), sponsored by Instituto Aragonés de Ciencias de la Salud. Primary endpoint: Assessment of the extent of acetylation at serine-529 of platelet COX-1 at Day 7. Started Apr 2013; status: completed.
02
Drugs
aspirin
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT02060396.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02060396.